|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.220 USD | -3.76% |
|
+3.60% | +2.87% |
| 06-29 | Xilio Therapeutics, Inc.(NasdaqCM:XLO) added to Russell Microcap Value Benchmark Index | CI |
| 06-29 | Xilio Therapeutics, Inc. Announces Appointment of Ben Harshbarger as Chief Legal Officer | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Neutral |
| Resistance | 9.58 | 10.13 | 11.45 |
| Spread/Res. | -3.76% | -8.97% | -19.49% |
| Spread/Supp. | +7.52% | +29.11% | +29.11% |
| Support | 8.575 | 7.141 | 7.141 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- XLO Stock
- Charts Xilio Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
